Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

Abstract Immune checkpoint inhibitors (ICIs) have demonstrated efficacy in advanced esophageal squamous cell carcinoma (ESCC). Heterogeneous responses to ICIs have been reported previously. Here, we describe a patient with advanced ESCC exhibiting a response to durvalumab plus tremelimumab for more...

Full description

Bibliographic Details
Main Authors: Jhe‐Cyuan Guo, Chia‐Lang Hsu, Min‐Shu Hsieh, Chia‐Chi Lin, Ta‐Chen Huang, Hung‐Yang Kuo, Yu‐Yun Shao, Chih‐Hung Hsu
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Thoracic Cancer
Subjects:
differential response
esophageal squamous cell carcinoma
immune checkpoint inhibitor
immune contexture
tumor site specific
Online Access:https://doi.org/10.1111/1759-7714.14997

Internet

https://doi.org/10.1111/1759-7714.14997

Similar Items